Home > Companies > GlaucoPharm
Last Update 15.4.2019Edit Profile
GlaucoPharm logo
GlaucoPharm
Topically Treating Glaucoma
Non Visible
Non Active, 4/2019 ceased to operate
 

About

GlaucoPharm is the developer of TG-46, a topical treatment for glaucoma. TG-46 is useful for the treatment of diseases modulated by the pyrimidinergic receptor P2Y6. The P2Y6 receptor has been identified in trabecular meshwork (TM) cells, an area of tissue in the eye that is responsible for draining the aqueous humor. The companys product shows evidence of a novel mechanism of action, making it a potential alternative to first-line drugs. It binds tightly and selectively to P2Y6R and reduces intraocular pressure by up to 45%, compared to the 25% to 35% reduction produced by most drugs on the market. TG-46 is highly stable chemically and enzymatically, with a duration of action longer than 3.5 hours. Its synthesis is facile and results in good yields, and preliminary data show that it causes fewer side effects than most standard treatments.

Founded

8/2013

Business models

B2B

Employees

1-10

Product stage

R&D

Products

TG-46

Geographic markets

-

Funding

Total Funding

Last Funding

-

Funding Stage

Seed

Total Rounds

1

Investors

2

The Team

(2)
OW
Orly Weinreb
CEO
Santiago Ini
Founder & CEO

Company Lifecycle

Event View
Timeline View

Public Offerings & Exits

Private Equity Funding

Non-Equity Funding

Mergers and Acquisitions

Others

Closing Event
Apr 2019

Use Cases (0)

Media gallery

(0)

Locations

Israel

Ha-Carmel 2, Yoqneam, Israel

Offices Abroad

Sector

Life Sciences & HealthTech
Pharma & Biomedicine
Discovery & Development

Core Technology

Biologicals

Target Industry

Healthcare & Life Sciences
Life Sciences
Pharmaceuticals

Tags

(3)
ophthalmology glaucoma eye-diseases

Target Markets

(0)

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Data and visuals presented here may not be used without the written consent of Start-Up Nation Finder.
Copyright © 2022 Terms of Use Privacy Policy